![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:FGFR1-GPR124 (FusionGDB2 ID:HG2260TG25960) |
Fusion Gene Summary for FGFR1-GPR124 |
![]() |
Fusion gene information | Fusion gene name: FGFR1-GPR124 | Fusion gene ID: hg2260tg25960 | Hgene | Tgene | Gene symbol | FGFR1 | GPR124 | Gene ID | 2260 | 25960 |
Gene name | fibroblast growth factor receptor 1 | adhesion G protein-coupled receptor A2 | |
Synonyms | BFGFR|CD331|CEK|ECCL|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1 | GPR124|TEM5 | |
Cytomap | ('FGFR1','FGFR1')('ADGRA2','GPR124') 8p11.23 | 8p11.23 | |
Type of gene | protein-coding | protein-coding | |
Description | fibroblast growth factor receptor 1FGFR1/PLAG1 fusionFMS-like tyrosine kinase 2basic fibroblast growth factor receptor 1fms-related tyrosine kinase 2heparin-binding growth factor receptorhydroxyaryl-protein kinaseproto-oncogene c-Fgr | adhesion G protein-coupled receptor A2G-protein coupled receptor 124tumor endothelial marker 5 | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | P11362 | . | |
Ensembl transtripts involved in fusion gene | ENST00000335922, ENST00000326324, ENST00000341462, ENST00000356207, ENST00000397091, ENST00000397103, ENST00000397113, ENST00000447712, ENST00000532791, ENST00000397108, ENST00000425967, ENST00000496629, | ||
Fusion gene scores | * DoF score | 17 X 24 X 9=3672 | 5 X 2 X 4=40 |
# samples | 20 | 5 | |
** MAII score | log2(20/3672*10)=-4.19849415363908 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/40*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: FGFR1 [Title/Abstract] AND GPR124 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | FGFR1(38314874)-ADGRA2(37672414), # samples:1 FGFR1(38314874)-GPR124(37672414), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | FGFR1-GPR124 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR1-GPR124 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR1-GPR124 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR1-GPR124 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR1-GPR124 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. FGFR1-GPR124 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. FGFR1-GPR124 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FGFR1 | GO:0008284 | positive regulation of cell proliferation | 8663044 |
Hgene | FGFR1 | GO:0008543 | fibroblast growth factor receptor signaling pathway | 8663044 |
Hgene | FGFR1 | GO:0010863 | positive regulation of phospholipase C activity | 18480409 |
Hgene | FGFR1 | GO:0018108 | peptidyl-tyrosine phosphorylation | 8622701|18480409 |
Hgene | FGFR1 | GO:0043406 | positive regulation of MAP kinase activity | 8622701|18480409 |
Hgene | FGFR1 | GO:0046777 | protein autophosphorylation | 8622701 |
Hgene | FGFR1 | GO:2000546 | positive regulation of endothelial cell chemotaxis to fibroblast growth factor | 21885851 |
Tgene | GPR124 | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 30026314 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-BH-A0EI-01A | FGFR1 | chr8 | 38314874 | - | ADGRA2 | chr8 | 37672414 | + |
ChimerDB4 | BRCA | TCGA-BH-A0EI-01A | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Top |
Fusion Gene ORF analysis for FGFR1-GPR124 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000335922 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
5UTR-3CDS | ENST00000335922 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000326324 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000326324 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000341462 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000341462 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000356207 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000356207 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000397091 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000397091 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000397103 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000397103 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000397113 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000397113 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000447712 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000447712 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000532791 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
Frame-shift | ENST00000532791 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
In-frame | ENST00000397108 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
In-frame | ENST00000397108 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
In-frame | ENST00000425967 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
In-frame | ENST00000425967 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
intron-3CDS | ENST00000496629 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
intron-3CDS | ENST00000496629 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000425967 | FGFR1 | chr8 | 38314874 | - | ENST00000315215 | GPR124 | chr8 | 37672414 | + | 6154 | 513 | 517 | 3612 | 1031 |
ENST00000425967 | FGFR1 | chr8 | 38314874 | - | ENST00000412232 | GPR124 | chr8 | 37672414 | + | 5885 | 513 | 517 | 4263 | 1248 |
ENST00000397108 | FGFR1 | chr8 | 38314874 | - | ENST00000315215 | GPR124 | chr8 | 37672414 | + | 6033 | 392 | 396 | 3491 | 1031 |
ENST00000397108 | FGFR1 | chr8 | 38314874 | - | ENST00000412232 | GPR124 | chr8 | 37672414 | + | 5764 | 392 | 396 | 4142 | 1248 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000425967 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + | 0.011757629 | 0.9882423 |
ENST00000425967 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + | 0.018235005 | 0.98176503 |
ENST00000397108 | ENST00000315215 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + | 0.011981729 | 0.9880183 |
ENST00000397108 | ENST00000412232 | FGFR1 | chr8 | 38314874 | - | GPR124 | chr8 | 37672414 | + | 0.016254837 | 0.9837451 |
Top |
Fusion Genomic Features for FGFR1-GPR124 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
FGFR1 | chr8 | 38314873 | - | GPR124 | chr8 | 37672413 | + | 2.46E-07 | 0.99999976 |
FGFR1 | chr8 | 38314873 | - | GPR124 | chr8 | 37672413 | + | 2.46E-07 | 0.99999976 |
![]() |
![]() |
![]() |
![]() |
Top |
Fusion Protein Features for FGFR1-GPR124 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:38314874/chr8:37672414) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
FGFR1 | . |
FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation. {ECO:0000250|UniProtKB:P16092, ECO:0000269|PubMed:10830168, ECO:0000269|PubMed:11353842, ECO:0000269|PubMed:12181353, ECO:0000269|PubMed:1379697, ECO:0000269|PubMed:1379698, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:19224897, ECO:0000269|PubMed:19261810, ECO:0000269|PubMed:19665973, ECO:0000269|PubMed:20133753, ECO:0000269|PubMed:20139426, ECO:0000269|PubMed:21765395, ECO:0000269|PubMed:8622701, ECO:0000269|PubMed:8663044}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 190_240 | 88 | 1122.0 | Domain | LRRCT | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 247_344 | 88 | 1122.0 | Domain | Ig-like | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 707_758 | 88 | 1122.0 | Domain | GPS | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 190_240 | 88 | 1339.0 | Domain | LRRCT | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 247_344 | 88 | 1339.0 | Domain | Ig-like | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 707_758 | 88 | 1339.0 | Domain | GPS | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 362_364 | 88 | 1122.0 | Motif | RGD | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 362_364 | 88 | 1339.0 | Motif | RGD | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 107_130 | 88 | 1122.0 | Repeat | LRR 2 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 131_154 | 88 | 1122.0 | Repeat | LRR 3 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 156_178 | 88 | 1122.0 | Repeat | LRR 4 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 107_130 | 88 | 1339.0 | Repeat | LRR 2 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 131_154 | 88 | 1339.0 | Repeat | LRR 3 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 156_178 | 88 | 1339.0 | Repeat | LRR 4 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 1041_1047 | 88 | 1122.0 | Topological domain | Extracellular | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 1069_1338 | 88 | 1122.0 | Topological domain | Cytoplasmic | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 793_807 | 88 | 1122.0 | Topological domain | Cytoplasmic | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 829_832 | 88 | 1122.0 | Topological domain | Extracellular | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 854_886 | 88 | 1122.0 | Topological domain | Cytoplasmic | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 908_924 | 88 | 1122.0 | Topological domain | Extracellular | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 946_1019 | 88 | 1122.0 | Topological domain | Cytoplasmic | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 1041_1047 | 88 | 1339.0 | Topological domain | Extracellular | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 1069_1338 | 88 | 1339.0 | Topological domain | Cytoplasmic | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 793_807 | 88 | 1339.0 | Topological domain | Cytoplasmic | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 829_832 | 88 | 1339.0 | Topological domain | Extracellular | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 854_886 | 88 | 1339.0 | Topological domain | Cytoplasmic | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 908_924 | 88 | 1339.0 | Topological domain | Extracellular | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 946_1019 | 88 | 1339.0 | Topological domain | Cytoplasmic | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 1020_1040 | 88 | 1122.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 1048_1068 | 88 | 1122.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 772_792 | 88 | 1122.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 808_828 | 88 | 1122.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 833_853 | 88 | 1122.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 887_907 | 88 | 1122.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 925_945 | 88 | 1122.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 1020_1040 | 88 | 1339.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 1048_1068 | 88 | 1339.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 772_792 | 88 | 1339.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 808_828 | 88 | 1339.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 833_853 | 88 | 1339.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 887_907 | 88 | 1339.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 925_945 | 88 | 1339.0 | Transmembrane | Helical%3B Name%3D5 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 158_246 | 30 | 732.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 255_357 | 30 | 732.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 25_119 | 30 | 732.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 478_767 | 30 | 732.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 158_246 | 0 | 813.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 255_357 | 0 | 813.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 25_119 | 0 | 813.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 478_767 | 0 | 813.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 158_246 | 30 | 734.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 255_357 | 30 | 734.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 25_119 | 30 | 734.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 478_767 | 30 | 734.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 158_246 | 30 | 821.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 255_357 | 30 | 821.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 25_119 | 30 | 821.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 478_767 | 30 | 821.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 158_246 | 30 | 821.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 255_357 | 30 | 821.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 25_119 | 30 | 821.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 478_767 | 30 | 821.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 158_246 | 30 | 821.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 255_357 | 30 | 821.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 25_119 | 30 | 821.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 478_767 | 30 | 821.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 158_246 | 63 | 854.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 255_357 | 63 | 854.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 25_119 | 63 | 854.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 478_767 | 63 | 854.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 158_246 | 30 | 823.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 255_357 | 30 | 823.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 25_119 | 30 | 823.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 478_767 | 30 | 823.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 158_246 | 30 | 821.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 255_357 | 30 | 821.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 25_119 | 30 | 821.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 478_767 | 30 | 821.0 | Domain | Protein kinase |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 484_490 | 30 | 732.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 562_564 | 30 | 732.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 484_490 | 0 | 813.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 562_564 | 0 | 813.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 484_490 | 30 | 734.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 562_564 | 30 | 734.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 484_490 | 30 | 821.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 562_564 | 30 | 821.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 484_490 | 30 | 821.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 562_564 | 30 | 821.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 484_490 | 30 | 821.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 562_564 | 30 | 821.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 484_490 | 63 | 854.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 562_564 | 63 | 854.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 484_490 | 30 | 823.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 562_564 | 30 | 823.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 484_490 | 30 | 821.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 562_564 | 30 | 821.0 | Nucleotide binding | Note=ATP |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 160_177 | 30 | 732.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 160_177 | 0 | 813.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 160_177 | 30 | 734.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 160_177 | 30 | 821.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 160_177 | 30 | 821.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 160_177 | 30 | 821.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 160_177 | 63 | 854.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 160_177 | 30 | 823.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 160_177 | 30 | 821.0 | Region | Note=Heparin-binding |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 22_376 | 30 | 732.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 398_822 | 30 | 732.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 22_376 | 0 | 813.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 398_822 | 0 | 813.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 22_376 | 30 | 734.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 398_822 | 30 | 734.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 22_376 | 30 | 821.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 398_822 | 30 | 821.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 22_376 | 30 | 821.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 398_822 | 30 | 821.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 22_376 | 30 | 821.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 398_822 | 30 | 821.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 22_376 | 63 | 854.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 398_822 | 63 | 854.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 22_376 | 30 | 823.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 398_822 | 30 | 823.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 22_376 | 30 | 821.0 | Topological domain | Extracellular |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 398_822 | 30 | 821.0 | Topological domain | Cytoplasmic |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000326324 | - | 2 | 17 | 377_397 | 30 | 732.0 | Transmembrane | Helical |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000335922 | - | 2 | 19 | 377_397 | 0 | 813.0 | Transmembrane | Helical |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000356207 | - | 2 | 17 | 377_397 | 30 | 734.0 | Transmembrane | Helical |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397091 | - | 2 | 18 | 377_397 | 30 | 821.0 | Transmembrane | Helical |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397108 | - | 3 | 19 | 377_397 | 30 | 821.0 | Transmembrane | Helical |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000397113 | - | 2 | 18 | 377_397 | 30 | 821.0 | Transmembrane | Helical |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000425967 | - | 3 | 19 | 377_397 | 63 | 854.0 | Transmembrane | Helical |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000447712 | - | 2 | 18 | 377_397 | 30 | 823.0 | Transmembrane | Helical |
Hgene | FGFR1 | chr8:38314874 | chr8:37672414 | ENST00000532791 | - | 2 | 18 | 377_397 | 30 | 821.0 | Transmembrane | Helical |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 82_106 | 88 | 1122.0 | Repeat | LRR 1 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 82_106 | 88 | 1339.0 | Repeat | LRR 1 | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000315215 | 0 | 16 | 34_771 | 88 | 1122.0 | Topological domain | Extracellular | |
Tgene | GPR124 | chr8:38314874 | chr8:37672414 | ENST00000412232 | 0 | 19 | 34_771 | 88 | 1339.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for FGFR1-GPR124 |
![]() |
>30243_30243_1_FGFR1-GPR124_FGFR1_chr8_38314874_ENST00000397108_GPR124_chr8_37672414_ENST00000315215_length(transcript)=6033nt_BP=392nt AACTTTTCCTCCAACTCGCGCTCGGGAGCTGGCGAGGCGGCGGCGGCTCCTCAAAGTGGGAGAGCTTCAAGGTCACGTGGTCCGTCCAGC CCCTGCTATCTCACCAGACACTGTCCACCCTGTATGTTGGATCAGTACTCCAGTGAGAAGACAGCAGGCACTTTCACCCATGCAGCCCAT TCAGTCTTCATAACCACCTGTGATGGAGGCAAGGGTCAGTTTGAAAAGGAGGATCGAGCTCACTGTGGAGTATCCATGGAGATGTGGAGC CTTGTCACCAACCTCTAACTGCAGAACTGGGATGTGGAGCTGGAAGTGCCTCCTCTTCTGGGCTGTGCTGGTCACAGCCACACTCTGCAC CGCTAGGCCGTCCCCGACCTTGCCTGAACAAGGCTCTTGAGCAATAACAAGATCACGGGGCTCCGCAATGGCTCCTTCCTGGGACTGTCA CTGCTGGAGAAGCTGGACCTGAGGAACAACATCATCAGCACAGTGCAGCCGGGCGCCTTCCTGGGCCTGGGGGAGCTGAAGCGTTTAGAT CTCTCCAACAACCGGATTGGCTGTCTCACCTCCGAGACCTTCCAGGGCCTCCCCAGGCTTCTCCGACTAAACATATCTGGAAACATCTTC TCCAGTCTGCAACCTGGGGTCTTTGATGAGCTGCCAGCCCTTAAGGTTGTGGACTTGGGCACCGAGTTCCTGACCTGTGACTGCCACCTG CGCTGGCTGCTGCCCTGGGCCCAGAATCGCTCCCTGCAGCTGTCGGAACACACGCTCTGTGCTTACCCCAGTGCCCTGCATGCTCAGGCC CTGGGCAGCCTCCAGGAGGCCCAGCTCTGCTGCGAGGGGGCCCTGGAGCTGCACACACACCACCTCATCCCGTCCCTACGCCAAGTGGTG TTCCAGGGGGATCGGCTGCCCTTCCAGTGCTCTGCCAGCTACCTGGGCAACGACACCCGCATCCGCTGGTACCACAACCGAGCCCCTGTG GAGGGTGATGAGCAGGCGGGCATCCTCCTGGCCGAGAGCCTCATCCACGACTGCACCTTCATCACCAGTGAGCTGACGCTGTCTCACATC GGCGTGTGGGCCTCAGGCGAGTGGGAGTGCACCGTGTCCATGGCCCAAGGCAACGCCAGCAAGAAGGTGGAGATCGTGGTGCTGGAGACC TCTGCCTCCTACTGCCCCGCCGAGCGTGTTGCCAACAACCGCGGGGACTTCAGGTGGCCCCGAACTCTGGCTGGCATCACAGCCTACCAG TCCTGCCTGCAGTATCCCTTCACCTCAGTGCCCCTGGGCGGGGGTGCCCCGGGCACCCGAGCCTCCCGCCGGTGTGACCGTGCCGGCCGC TGGGAGCCAGGGGACTACTCCCACTGTCTCTACACCAACGACATCACCAGGGTGCTGTACACCTTCGTGCTGATGCCCATCAATGCCTCC AATGCGCTGACCCTGGCTCACCAGCTGCGCGTGTACACAGCCGAGGCCGCTAGCTTTTCAGACATGATGGATGTAGTCTATGTGGCTCAG ATGATCCAGAAATTTTTGGGTTATGTCGACCAGATCAAAGAGCTGGTAGAGGTGATGGTGGACATGGCCAGCAACCTGATGCTGGTGGAC GAGCACCTGCTGTGGCTGGCCCAGCGCGAGGACAAGGCCTGCAGCCGCATCGTGGGTGCCCTGGAGCGCATTGGGGGGGCCGCCCTCAGC CCCCATGCCCAGCACATCTCAGTGGAGCTGAGCGCCTTTCCCAGGGAGGTGGGGGGCGCCGGGGCAGGGCTGCACCCCGTGGTATACCCC TGCACGGCCTTGCTGCTGCTCTGCCTCTTCGCCACCATCATCACCTACATCCTCAACCACAGCTCCATCCGTGTGTCCCGGAAAGGCTGG CACATGCTGCTGAACTTGTGCTTCCACATAGCCATGACCTCTGCTGTCTTTGCGGGGGGCATCACACTCACCAACTACCAGATGGTCTGC CAGGCGGTGGGCATCACCCTGCACTACTCCTCCCTATCCACGCTGCTCTGGATGGGCGTGAAGGCGCGAGTGCTCCATAAGGAGCTCACC TGGAGGGCACCCCCTCCGCAAGAAGGGGACCCCGCTCTGCCTACTCCCAGTCCTATGCTCCGGTTCTATTTGATCGCTGGAGGGATTCCA CTCATTATCTGTGGCATCACAGCTGCAGTCAACATCCACAACTACCGGGACCACAGCCCCTACTGCTGGCTGGTGTGGCGTCCAAGCCTT GGCGCCTTCTACATCCCTGTGGCTTTGATTCTGCTCATCACCTGGATCTATTTCCTGTGCGCCGGGCTACGCTTACGGGGTCCTCTGGCA CAGAACCCCAAGGCGGGCAACAGCAGGGCCTCCCTGGAGGCAGGGGAGGAGCTGAGGGGTTCCACCAGGCTCAGGGGCAGCGGCCCCCTC CTGAGTGACTCAGGTTCCCTTCTTGCTACTGGGAGCGCGCGAGTGGGGACGCCCGGGCCCCCGGAGGATGGTGACAGCCTCTATTCTCCG GGAGTCCAGCTAGGGGCGCTGGTGACCACGCACTTCCTGTACTTGGCCATGTGGGCCTGCGGGGCTCTGGCAGTGTCCCAGCGCTGGCTG CCCCGGGTGGTGTGCAGCTGCTTGTACGGGGTGGCAGCCTCCGCCCTGGGCCTCTTCGTCTTCACTCACCACTGTGCCAGGCGGAGGGAC GTGAGAGCCTCGTGGCGCGCCTGCTGCCCCCCTGCCTCTCCCGCGGCCCCCCATGCCCCGCCCCGGGCCCTGCCCGCCGCCGCAGAGGAC GGTTCCCCGGTGTTCGGGGAGGGCCCCCCCTCCCTCAAGTCCTCCCCAAGCGGCAGCAGCGGCCATCCGCTGGCTCTGGGCCCCTGCAAG CTCACCAACCTGCAGCTGGCCCAGAGTCAGGTGTGCGAGGCGGGGGCGGCGGCCGGCGGGGAAGGAGAGCCGGAGCCGGCGGGCACCCGG GGAAACCTCGCCCACCGCCACCCCAACAACGTGCACCACGGGCGTCGGGCGCACAAGAGCCGGGCCAAGGGACACCGCGCGGGGGAGGCC TGCGGCAAGAACCGGCTCAAGGCCCTGCGCGGGGGCGCGGCGGGGGCGCTGGAGCTGCTGTCCAGCGAGAGCGGCAGTCTGCACAACAGC CCCACCGACAGCTACCTGGGCAGCAGCCGCAACAGCCCGGGCGCCGGCCTGCAGCTGGAAGGCGAGCCCATGCTCACGCCGTCCGAGGGC AGCGACACCAGCGCCGCGCCGCTTTCTGAGGCGGGCCGGGCAGGCCAGCGCCGCAGCGCCAGCCGCGACAGTCTCAAGGGCGGCGGCGCG CTGGAGAAGGAGAGCCATCGCCGCTCGTACCCGCTCAACGCCGCCAGCCTAAACGGCGCCCCCAAGGGGGGCAAGTACGACGACGTCACC CTGATGGGCGCGGAGGTAGCCAGCGGCGGCTGCATGAAGACCGGACTCTGGAAGAGCGAAACTACCGTCTAAGGTGGGGCGGGCGACGCG GTAGACGGGCTGGCCACGCGGCTCGTTCCCCCGCTCCTCGGGGCCCTCCAAGGTGTCTCCGTAGTCAGCAGGTTGGAGGCAGAGGAGCCG ATGGCTGGAGGAAGCCCACAGGCGGATGTTCCCCACTTGCCTAGAGGGCATCCCTCTGGGGTAGCGACAGACAATCCCAGAAACACGCAT AATACATTTCCGTCCAGCCCGGGGCAGTCTGACTGTCGGTGCCCTCCCAGGAACGGGGAAGGCCTCCGTCTGTGTGAAAGGGCACAGCAC ATCCCAGGTGCACCCTCCCCAAGTACTCCCACCCCGCCTACTGTCCATGCGGCCTCACTGGGGGCCATCAGCCTCACCAGCAAAGCAGAG ATGAGAGCGTGGGAACTGTGTTCTTTCCTCCCTGCCCTCTACTGATTTCAGCCCAGCCCCTGCCTAGATCCTAGGTCCCTTTTCCTCCCG AGTTTGGCTGGCACGAGAGCTAGCCCAGCACATGAAGCAGGTGATGTTAAGTCACAAGGTGCTGCTTTTCAGATCCACTATGCAAGAGGG GAGGGTGGGGCCACGTGAAAGGCAGCTCTAGACATCAACCAGTCCTGGGGGAGGGGAGTGGGAACCGGGCACAACTAGGAACAATGCCAC CATTCCCACAGGAGTGGTACTTAAACCAGACAGCAGGGTTCAGAGGTGGCACACCGGGACAAAGCTGAGGCCCTGCACCTCAACAGCTGA CTGCCAGGTGCCTGTGGGTGAACTGAGGGGAGTAGAGGGAGAGGGCAGGTGGAACTGGGGCAGAATCTAGTCATGCCCTAAAGCTAGTCC TGTAAACAATGGTGCCCCAGAAAGCTGCAGGTGGTGTTTGGAGAAGCAGTTACTTTTCAGTTACAAGACCCATCTCCCTAGTCTCAGCCT TACAACACCACGGGACTAAGGAAGAGCACTTCCTTGCCTCCGTAAGGCCAGAGGAAGAACCATCCCAATCATTTGATCTCCAGCTCCACA GTAGAGAGAAACCTACAAAATGTCAAACCAGCTTCCCGACTCCCAGGAGCTCAAGCCAAGCCCAGAGGCAGTGGCTGGGGTCCCTGCAGG TCATGAGGGGCCTATGCCTTTACTCCTTTTAAACACCAGCACCCGTCTTTTCCCCAACCTAAAACCAACCACCAGCATTTCACTACAGGA CCAAATGGAAACCGAGGGAACCCTGGGTCTTGGGAAGAACAACAGGAAACCAAGGTCTGACCTAGGGTTCCCTCCCAGTCTTCACATCAC TCTGGCCTCATCACCAAGGTGACAGAGGACACAGGGGAGGGGGAAAACCCACACACACTCCTTGGAATGGGTCCTGTTATTTATGCTTGC TGCACAGACATATTAGAAGAAAAAAAAAAGCTTTGTATTATTCTTCCACATATGCTGGCTGCTGTTTACACACCCTGCCAATGCCTTAGC ACTGGAGAGCTTTTTGCAATATGCTGGGGAAAGGGGAGGGAGGGAATGAAAGTGCCAAAGAAAACATGTTTTTAAGAACTCGGGTTTTAT ACAATAGAATGTTTTCTAGCAGATGCCTCTTGTTTTAATATATTAAAATTTTGCAAAGCCCTTTGAGCTACTGCCTTAGTCTACCCACTG TCCTTTTGTTATGAGGTAGAGGATCTCATGACACCATACACACAAACCCATCATTGCCTGTGAATGCACGTAGGGCCAGAATTCCCCAGT TCCCGCTCCTCTGAGGGTTGATACTGCTGGGAATGCCAACCACTCCACAAGCAGAGGGAAGCCCCCTCAGGCCTGCAGGAGGAGCCGCAG CAGTGTGTCCAATTCAAACCAGCAGCAAAGAGCCTGACATTTTCCCATCCATCTATGAGGAAAGCCATCTCACAGAACATGGACATAGGC AACTTGCTCTCCCACACCAAGGGATGGGAATCTCTCCTACCTATAGTCATCCCTGCACTCCTGACTTTACTCCAGGACCCAGGGTCCAAC TAATGGCAGAGCCCCTCTTGGTTCCTTCAAACAAGAAAAGCAATACCTACGGACTGGTGTACACTTCCATCCTTGGTTATAACAGGAATG TTATCAAGCTGTCAGAACAGGATGAAGTGCTCCCAGTGGATATCCATCAGGGAGGGTTAGGGACACTCGTGGCAGCCTGTCTAGCAGCCT GGGCTCTCTGAAAGTCCCTAACTTCCTGAGGGGTACGCAAATACTGTTCTATTTCACTATCAGAAATGTTCTCATCTCCAGTGACAGTGG AGACAGGGGGTACAGGGCAGATCCGCTTCGGGGACTTCAACATGCAGGGTGGCAAGAGAAGGGCAGGACTGGCCGGCCGCTTCCCCTGGG GTAAACCTAAGGAATTATTTCCCACCTCCCCTTCTCCTTGCCCCTGTCCCCACCCCGGTGGCTCCTTCTCTCGGGTCTCCACTTCTGCTG TCCCATCCCGAAAGGCAGAGCGGACCAGTGACTGGCGGTGCTGGAGAAGGTCACCGATGTGCTTCACCACAGACCGTTTGTCAAGTCTCA >30243_30243_1_FGFR1-GPR124_FGFR1_chr8_38314874_ENST00000397108_GPR124_chr8_37672414_ENST00000315215_length(amino acids)=1031AA_BP=1 MSNNKITGLRNGSFLGLSLLEKLDLRNNIISTVQPGAFLGLGELKRLDLSNNRIGCLTSETFQGLPRLLRLNISGNIFSSLQPGVFDELP ALKVVDLGTEFLTCDCHLRWLLPWAQNRSLQLSEHTLCAYPSALHAQALGSLQEAQLCCEGALELHTHHLIPSLRQVVFQGDRLPFQCSA SYLGNDTRIRWYHNRAPVEGDEQAGILLAESLIHDCTFITSELTLSHIGVWASGEWECTVSMAQGNASKKVEIVVLETSASYCPAERVAN NRGDFRWPRTLAGITAYQSCLQYPFTSVPLGGGAPGTRASRRCDRAGRWEPGDYSHCLYTNDITRVLYTFVLMPINASNALTLAHQLRVY TAEAASFSDMMDVVYVAQMIQKFLGYVDQIKELVEVMVDMASNLMLVDEHLLWLAQREDKACSRIVGALERIGGAALSPHAQHISVELSA FPREVGGAGAGLHPVVYPCTALLLLCLFATIITYILNHSSIRVSRKGWHMLLNLCFHIAMTSAVFAGGITLTNYQMVCQAVGITLHYSSL STLLWMGVKARVLHKELTWRAPPPQEGDPALPTPSPMLRFYLIAGGIPLIICGITAAVNIHNYRDHSPYCWLVWRPSLGAFYIPVALILL ITWIYFLCAGLRLRGPLAQNPKAGNSRASLEAGEELRGSTRLRGSGPLLSDSGSLLATGSARVGTPGPPEDGDSLYSPGVQLGALVTTHF LYLAMWACGALAVSQRWLPRVVCSCLYGVAASALGLFVFTHHCARRRDVRASWRACCPPASPAAPHAPPRALPAAAEDGSPVFGEGPPSL KSSPSGSSGHPLALGPCKLTNLQLAQSQVCEAGAAAGGEGEPEPAGTRGNLAHRHPNNVHHGRRAHKSRAKGHRAGEACGKNRLKALRGG AAGALELLSSESGSLHNSPTDSYLGSSRNSPGAGLQLEGEPMLTPSEGSDTSAAPLSEAGRAGQRRSASRDSLKGGGALEKESHRRSYPL -------------------------------------------------------------- >30243_30243_2_FGFR1-GPR124_FGFR1_chr8_38314874_ENST00000397108_GPR124_chr8_37672414_ENST00000412232_length(transcript)=5764nt_BP=392nt AACTTTTCCTCCAACTCGCGCTCGGGAGCTGGCGAGGCGGCGGCGGCTCCTCAAAGTGGGAGAGCTTCAAGGTCACGTGGTCCGTCCAGC CCCTGCTATCTCACCAGACACTGTCCACCCTGTATGTTGGATCAGTACTCCAGTGAGAAGACAGCAGGCACTTTCACCCATGCAGCCCAT TCAGTCTTCATAACCACCTGTGATGGAGGCAAGGGTCAGTTTGAAAAGGAGGATCGAGCTCACTGTGGAGTATCCATGGAGATGTGGAGC CTTGTCACCAACCTCTAACTGCAGAACTGGGATGTGGAGCTGGAAGTGCCTCCTCTTCTGGGCTGTGCTGGTCACAGCCACACTCTGCAC CGCTAGGCCGTCCCCGACCTTGCCTGAACAAGGCTCTTGAGCAATAACAAGATCACGGGGCTCCGCAATGGCTCCTTCCTGGGACTGTCA CTGCTGGAGAAGCTGGACCTGAGGAACAACATCATCAGCACAGTGCAGCCGGGCGCCTTCCTGGGCCTGGGGGAGCTGAAGCGTTTAGAT CTCTCCAACAACCGGATTGGCTGTCTCACCTCCGAGACCTTCCAGGGCCTCCCCAGGCTTCTCCGACTAAACATATCTGGAAACATCTTC TCCAGTCTGCAACCTGGGGTCTTTGATGAGCTGCCAGCCCTTAAGGTTGTGGACTTGGGCACCGAGTTCCTGACCTGTGACTGCCACCTG CGCTGGCTGCTGCCCTGGGCCCAGAATCGCTCCCTGCAGCTGTCGGAACACACGCTCTGTGCTTACCCCAGTGCCCTGCATGCTCAGGCC CTGGGCAGCCTCCAGGAGGCCCAGCTCTGCTGCGAGGGGGCCCTGGAGCTGCACACACACCACCTCATCCCGTCCCTACGCCAAGTGGTG TTCCAGGGGGATCGGCTGCCCTTCCAGTGCTCTGCCAGCTACCTGGGCAACGACACCCGCATCCGCTGGTACCACAACCGAGCCCCTGTG GAGGGTGATGAGCAGGCGGGCATCCTCCTGGCCGAGAGCCTCATCCACGACTGCACCTTCATCACCAGTGAGCTGACGCTGTCTCACATC GGCGTGTGGGCCTCAGGCGAGTGGGAGTGCACCGTGTCCATGGCCCAAGGCAACGCCAGCAAGAAGGTGGAGATCGTGGTGCTGGAGACC TCTGCCTCCTACTGCCCCGCCGAGCGTGTTGCCAACAACCGCGGGGACTTCAGGTGGCCCCGAACTCTGGCTGGCATCACAGCCTACCAG TCCTGCCTGCAGTATCCCTTCACCTCAGTGCCCCTGGGCGGGGGTGCCCCGGGCACCCGAGCCTCCCGCCGGTGTGACCGTGCCGGCCGC TGGGAGCCAGGGGACTACTCCCACTGTCTCTACACCAACGACATCACCAGGGTGCTGTACACCTTCGTGCTGATGCCCATCAATGCCTCC AATGCGCTGACCCTGGCTCACCAGCTGCGCGTGTACACAGCCGAGGCCGCTAGCTTTTCAGACATGATGGATGTAGTCTATGTGGCTCAG ATGATCCAGAAATTTTTGGGTTATGTCGACCAGATCAAAGAGCTGGTAGAGGTGATGGTGGACATGGCCAGCAACCTGATGCTGGTGGAC GAGCACCTGCTGTGGCTGGCCCAGCGCGAGGACAAGGCCTGCAGCCGCATCGTGGGTGCCCTGGAGCGCATTGGGGGGGCCGCCCTCAGC CCCCATGCCCAGCACATCTCAGTGAATGCGAGGAACGTGGCATTGGAGGCCTACCTCATCAAGCCGCACAGCTACGTGGGCCTGACCTGC ACAGCCTTCCAGAGGAGGGAGGGAGGGGTGCCGGGCACACGGCCAGGAAGCCCTGGCCAGAACCCCCCACCTGAGCCCGAGCCCCCAGCT GACCAGCAGCTCCGCTTCCGCTGCACCACCGGGAGGCCCAATGTTTCTCTGTCGTCCTTCCACATCAAGAACAGCGTGGCCCTGGCCTCC ATCCAGCTGCCCCCGAGTCTATTCTCATCCCTTCCGGCTGCCCTGGCTCCCCCGGTGCCCCCAGACTGCACCCTGCAACTGCTCGTCTTC CGAAATGGCCGCCTCTTCCACAGCCACAGCAACACCTCCCGCCCTGGAGCTGCTGGGCCTGGCAAGAGGCGTGGCGTGGCCACCCCCGTC ATCTTCGCAGGAACCAGTGGCTGTGGCGTGGGAAACCTGACAGAGCCAGTGGCCGTTTCGCTGCGGCACTGGGCTGAGGGAGCCGAACCT GTGGCCGCTTGGTGGAGCCAGGAGGGGCCCGGGGAGGCTGGGGGCTGGACCTCGGAGGGCTGCCAGCTCCGCTCCAGCCAGCCCAATGTC AGCGCCCTGCACTGCCAGCACTTGGGCAATGTGGCCGTGCTCATGGAGCTGAGCGCCTTTCCCAGGGAGGTGGGGGGCGCCGGGGCAGGG CTGCACCCCGTGGTATACCCCTGCACGGCCTTGCTGCTGCTCTGCCTCTTCGCCACCATCATCACCTACATCCTCAACCACAGCTCCATC CGTGTGTCCCGGAAAGGCTGGCACATGCTGCTGAACTTGTGCTTCCACATAGCCATGACCTCTGCTGTCTTTGCGGGGGGCATCACACTC ACCAACTACCAGATGGTCTGCCAGGCGGTGGGCATCACCCTGCACTACTCCTCCCTATCCACGCTGCTCTGGATGGGCGTGAAGGCGCGA GTGCTCCATAAGGAGCTCACCTGGAGGGCACCCCCTCCGCAAGAAGGGGACCCCGCTCTGCCTACTCCCAGTCCTATGCTCCGGTTCTAT TTGATCGCTGGAGGGATTCCACTCATTATCTGTGGCATCACAGCTGCAGTCAACATCCACAACTACCGGGACCACAGCCCCTACTGCTGG CTGGTGTGGCGTCCAAGCCTTGGCGCCTTCTACATCCCTGTGGCTTTGATTCTGCTCATCACCTGGATCTATTTCCTGTGCGCCGGGCTA CGCTTACGGGGTCCTCTGGCACAGAACCCCAAGGCGGGCAACAGCAGGGCCTCCCTGGAGGCAGGGGAGGAGCTGAGGGGTTCCACCAGG CTCAGGGGCAGCGGCCCCCTCCTGAGTGACTCAGGTTCCCTTCTTGCTACTGGGAGCGCGCGAGTGGGGACGCCCGGGCCCCCGGAGGAT GGTGACAGCCTCTATTCTCCGGGAGTCCAGCTAGGGGCGCTGGTGACCACGCACTTCCTGTACTTGGCCATGTGGGCCTGCGGGGCTCTG GCAGTGTCCCAGCGCTGGCTGCCCCGGGTGGTGTGCAGCTGCTTGTACGGGGTGGCAGCCTCCGCCCTGGGCCTCTTCGTCTTCACTCAC CACTGTGCCAGGCGGAGGGACGTGAGAGCCTCGTGGCGCGCCTGCTGCCCCCCTGCCTCTCCCGCGGCCCCCCATGCCCCGCCCCGGGCC CTGCCCGCCGCCGCAGAGGACGGTTCCCCGGTGTTCGGGGAGGGCCCCCCCTCCCTCAAGTCCTCCCCAAGCGGCAGCAGCGGCCATCCG CTGGCTCTGGGCCCCTGCAAGCTCACCAACCTGCAGCTGGCCCAGAGTCAGGTGTGCGAGGCGGGGGCGGCGGCCGGCGGGGAAGGAGAG CCGGAGCCGGCGGGCACCCGGGGAAACCTCGCCCACCGCCACCCCAACAACGTGCACCACGGGCGTCGGGCGCACAAGAGCCGGGCCAAG GGACACCGCGCGGGGGAGGCCTGCGGCAAGAACCGGCTCAAGGCCCTGCGCGGGGGCGCGGCGGGGGCGCTGGAGCTGCTGTCCAGCGAG AGCGGCAGTCTGCACAACAGCCCCACCGACAGCTACCTGGGCAGCAGCCGCAACAGCCCGGGCGCCGGCCTGCAGCTGGAAGGCGAGCCC ATGCTCACGCCGTCCGAGGGCAGCGACACCAGCGCCGCGCCGCTTTCTGAGGCGGGCCGGGCAGGCCAGCGCCGCAGCGCCAGCCGCGAC AGTCTCAAGGGCGGCGGCGCGCTGGAGAAGGAGAGCCATCGCCGCTCGTACCCGCTCAACGCCGCCAGCCTAAACGGCGCCCCCAAGGGG GGCAAGTACGACGACGTCACCCTGATGGGCGCGGAGGTAGCCAGCGGCGGCTGCATGAAGACCGGACTCTGGAAGAGCGAAACTACCGTC TAAGGTGGGGCGGGCGACGCGGTAGACGGGCTGGCCACGCGGCTCGTTCCCCCGCTCCTCGGGGCCCTCCAAGGTGTCTCCGTAGTCAGC AGGTTGGAGGCAGAGGAGCCGATGGCTGGAGGAAGCCCACAGGCGGATGTTCCCCACTTGCCTAGAGGGCATCCCTCTGGGGTAGCGACA GACAATCCCAGAAACACGCATAATACATTTCCGTCCAGCCCGGGGCAGTCTGACTGTCGGTGCCCTCCCAGGAACGGGGAAGGCCTCCGT CTGTGTGAAAGGGCACAGCACATCCCAGGTGCACCCTCCCCAAGTACTCCCACCCCGCCTACTGTCCATGCGGCCTCACTGGGGGCCATC AGCCTCACCAGCAAAGCAGAGATGAGAGCGTGGGAACTGTGTTCTTTCCTCCCTGCCCTCTACTGATTTCAGCCCAGCCCCTGCCTAGAT CCTAGGTCCCTTTTCCTCCCGAGTTTGGCTGGCACGAGAGCTAGCCCAGCACATGAAGCAGGTGATGTTAAGTCACAAGGTGCTGCTTTT CAGATCCACTATGCAAGAGGGGAGGGTGGGGCCACGTGAAAGGCAGCTCTAGACATCAACCAGTCCTGGGGGAGGGGAGTGGGAACCGGG CACAACTAGGAACAATGCCACCATTCCCACAGGAGTGGTACTTAAACCAGACAGCAGGGTTCAGAGGTGGCACACCGGGACAAAGCTGAG GCCCTGCACCTCAACAGCTGACTGCCAGGTGCCTGTGGGTGAACTGAGGGGAGTAGAGGGAGAGGGCAGGTGGAACTGGGGCAGAATCTA GTCATGCCCTAAAGCTAGTCCTGTAAACAATGGTGCCCCAGAAAGCTGCAGGTGGTGTTTGGAGAAGCAGTTACTTTTCAGTTACAAGAC CCATCTCCCTAGTCTCAGCCTTACAACACCACGGGACTAAGGAAGAGCACTTCCTTGCCTCCGTAAGGCCAGAGGAAGAACCATCCCAAT CATTTGATCTCCAGCTCCACAGTAGAGAGAAACCTACAAAATGTCAAACCAGCTTCCCGACTCCCAGGAGCTCAAGCCAAGCCCAGAGGC AGTGGCTGGGGTCCCTGCAGGTCATGAGGGGCCTATGCCTTTACTCCTTTTAAACACCAGCACCCGTCTTTTCCCCAACCTAAAACCAAC CACCAGCATTTCACTACAGGACCAAATGGAAACCGAGGGAACCCTGGGTCTTGGGAAGAACAACAGGAAACCAAGGTCTGACCTAGGGTT CCCTCCCAGTCTTCACATCACTCTGGCCTCATCACCAAGGTGACAGAGGACACAGGGGAGGGGGAAAACCCACACACACTCCTTGGAATG GGTCCTGTTATTTATGCTTGCTGCACAGACATATTAGAAGAAAAAAAAAAGCTTTGTATTATTCTTCCACATATGCTGGCTGCTGTTTAC ACACCCTGCCAATGCCTTAGCACTGGAGAGCTTTTTGCAATATGCTGGGGAAAGGGGAGGGAGGGAATGAAAGTGCCAAAGAAAACATGT TTTTAAGAACTCGGGTTTTATACAATAGAATGTTTTCTAGCAGATGCCTCTTGTTTTAATATATTAAAATTTTGCAAAGCCCTTTGAGCT >30243_30243_2_FGFR1-GPR124_FGFR1_chr8_38314874_ENST00000397108_GPR124_chr8_37672414_ENST00000412232_length(amino acids)=1248AA_BP=1 MSNNKITGLRNGSFLGLSLLEKLDLRNNIISTVQPGAFLGLGELKRLDLSNNRIGCLTSETFQGLPRLLRLNISGNIFSSLQPGVFDELP ALKVVDLGTEFLTCDCHLRWLLPWAQNRSLQLSEHTLCAYPSALHAQALGSLQEAQLCCEGALELHTHHLIPSLRQVVFQGDRLPFQCSA SYLGNDTRIRWYHNRAPVEGDEQAGILLAESLIHDCTFITSELTLSHIGVWASGEWECTVSMAQGNASKKVEIVVLETSASYCPAERVAN NRGDFRWPRTLAGITAYQSCLQYPFTSVPLGGGAPGTRASRRCDRAGRWEPGDYSHCLYTNDITRVLYTFVLMPINASNALTLAHQLRVY TAEAASFSDMMDVVYVAQMIQKFLGYVDQIKELVEVMVDMASNLMLVDEHLLWLAQREDKACSRIVGALERIGGAALSPHAQHISVNARN VALEAYLIKPHSYVGLTCTAFQRREGGVPGTRPGSPGQNPPPEPEPPADQQLRFRCTTGRPNVSLSSFHIKNSVALASIQLPPSLFSSLP AALAPPVPPDCTLQLLVFRNGRLFHSHSNTSRPGAAGPGKRRGVATPVIFAGTSGCGVGNLTEPVAVSLRHWAEGAEPVAAWWSQEGPGE AGGWTSEGCQLRSSQPNVSALHCQHLGNVAVLMELSAFPREVGGAGAGLHPVVYPCTALLLLCLFATIITYILNHSSIRVSRKGWHMLLN LCFHIAMTSAVFAGGITLTNYQMVCQAVGITLHYSSLSTLLWMGVKARVLHKELTWRAPPPQEGDPALPTPSPMLRFYLIAGGIPLIICG ITAAVNIHNYRDHSPYCWLVWRPSLGAFYIPVALILLITWIYFLCAGLRLRGPLAQNPKAGNSRASLEAGEELRGSTRLRGSGPLLSDSG SLLATGSARVGTPGPPEDGDSLYSPGVQLGALVTTHFLYLAMWACGALAVSQRWLPRVVCSCLYGVAASALGLFVFTHHCARRRDVRASW RACCPPASPAAPHAPPRALPAAAEDGSPVFGEGPPSLKSSPSGSSGHPLALGPCKLTNLQLAQSQVCEAGAAAGGEGEPEPAGTRGNLAH RHPNNVHHGRRAHKSRAKGHRAGEACGKNRLKALRGGAAGALELLSSESGSLHNSPTDSYLGSSRNSPGAGLQLEGEPMLTPSEGSDTSA -------------------------------------------------------------- >30243_30243_3_FGFR1-GPR124_FGFR1_chr8_38314874_ENST00000425967_GPR124_chr8_37672414_ENST00000315215_length(transcript)=6154nt_BP=513nt CCCTTTCACCTCCTGGCTCCCTCCCGGGCGATCCGCGCCCCTTGGGTCTCCCCTCCCTTCCCTCCGTCCGCGTCTCCTGCGCCCCCTCCC TGCGCTCGTCCCGCCGCTCTTCCCGCCGCCCAACTTTTCCTCCAACTCGCGCTCGGGAGCTGGCGAGGCGGCGGCGGCTCCTCAAAGTGG GAGAGCTTCAAGGTCACGTGGTCCGTCCAGCCCCTGCTATCTCACCAGACACTGTCCACCCTGTATGTTGGATCAGTACTCCAGTGAGAA GACAGCAGGCACTTTCACCCATGCAGCCCATTCAGTCTTCATAACCACCTGTGATGGAGGCAAGGGTCAGTTTGAAAAGGAGGATCGAGC TCACTGTGGAGTATCCATGGAGATGTGGAGCCTTGTCACCAACCTCTAACTGCAGAACTGGGATGTGGAGCTGGAAGTGCCTCCTCTTCT GGGCTGTGCTGGTCACAGCCACACTCTGCACCGCTAGGCCGTCCCCGACCTTGCCTGAACAAGGCTCTTGAGCAATAACAAGATCACGGG GCTCCGCAATGGCTCCTTCCTGGGACTGTCACTGCTGGAGAAGCTGGACCTGAGGAACAACATCATCAGCACAGTGCAGCCGGGCGCCTT CCTGGGCCTGGGGGAGCTGAAGCGTTTAGATCTCTCCAACAACCGGATTGGCTGTCTCACCTCCGAGACCTTCCAGGGCCTCCCCAGGCT TCTCCGACTAAACATATCTGGAAACATCTTCTCCAGTCTGCAACCTGGGGTCTTTGATGAGCTGCCAGCCCTTAAGGTTGTGGACTTGGG CACCGAGTTCCTGACCTGTGACTGCCACCTGCGCTGGCTGCTGCCCTGGGCCCAGAATCGCTCCCTGCAGCTGTCGGAACACACGCTCTG TGCTTACCCCAGTGCCCTGCATGCTCAGGCCCTGGGCAGCCTCCAGGAGGCCCAGCTCTGCTGCGAGGGGGCCCTGGAGCTGCACACACA CCACCTCATCCCGTCCCTACGCCAAGTGGTGTTCCAGGGGGATCGGCTGCCCTTCCAGTGCTCTGCCAGCTACCTGGGCAACGACACCCG CATCCGCTGGTACCACAACCGAGCCCCTGTGGAGGGTGATGAGCAGGCGGGCATCCTCCTGGCCGAGAGCCTCATCCACGACTGCACCTT CATCACCAGTGAGCTGACGCTGTCTCACATCGGCGTGTGGGCCTCAGGCGAGTGGGAGTGCACCGTGTCCATGGCCCAAGGCAACGCCAG CAAGAAGGTGGAGATCGTGGTGCTGGAGACCTCTGCCTCCTACTGCCCCGCCGAGCGTGTTGCCAACAACCGCGGGGACTTCAGGTGGCC CCGAACTCTGGCTGGCATCACAGCCTACCAGTCCTGCCTGCAGTATCCCTTCACCTCAGTGCCCCTGGGCGGGGGTGCCCCGGGCACCCG AGCCTCCCGCCGGTGTGACCGTGCCGGCCGCTGGGAGCCAGGGGACTACTCCCACTGTCTCTACACCAACGACATCACCAGGGTGCTGTA CACCTTCGTGCTGATGCCCATCAATGCCTCCAATGCGCTGACCCTGGCTCACCAGCTGCGCGTGTACACAGCCGAGGCCGCTAGCTTTTC AGACATGATGGATGTAGTCTATGTGGCTCAGATGATCCAGAAATTTTTGGGTTATGTCGACCAGATCAAAGAGCTGGTAGAGGTGATGGT GGACATGGCCAGCAACCTGATGCTGGTGGACGAGCACCTGCTGTGGCTGGCCCAGCGCGAGGACAAGGCCTGCAGCCGCATCGTGGGTGC CCTGGAGCGCATTGGGGGGGCCGCCCTCAGCCCCCATGCCCAGCACATCTCAGTGGAGCTGAGCGCCTTTCCCAGGGAGGTGGGGGGCGC CGGGGCAGGGCTGCACCCCGTGGTATACCCCTGCACGGCCTTGCTGCTGCTCTGCCTCTTCGCCACCATCATCACCTACATCCTCAACCA CAGCTCCATCCGTGTGTCCCGGAAAGGCTGGCACATGCTGCTGAACTTGTGCTTCCACATAGCCATGACCTCTGCTGTCTTTGCGGGGGG CATCACACTCACCAACTACCAGATGGTCTGCCAGGCGGTGGGCATCACCCTGCACTACTCCTCCCTATCCACGCTGCTCTGGATGGGCGT GAAGGCGCGAGTGCTCCATAAGGAGCTCACCTGGAGGGCACCCCCTCCGCAAGAAGGGGACCCCGCTCTGCCTACTCCCAGTCCTATGCT CCGGTTCTATTTGATCGCTGGAGGGATTCCACTCATTATCTGTGGCATCACAGCTGCAGTCAACATCCACAACTACCGGGACCACAGCCC CTACTGCTGGCTGGTGTGGCGTCCAAGCCTTGGCGCCTTCTACATCCCTGTGGCTTTGATTCTGCTCATCACCTGGATCTATTTCCTGTG CGCCGGGCTACGCTTACGGGGTCCTCTGGCACAGAACCCCAAGGCGGGCAACAGCAGGGCCTCCCTGGAGGCAGGGGAGGAGCTGAGGGG TTCCACCAGGCTCAGGGGCAGCGGCCCCCTCCTGAGTGACTCAGGTTCCCTTCTTGCTACTGGGAGCGCGCGAGTGGGGACGCCCGGGCC CCCGGAGGATGGTGACAGCCTCTATTCTCCGGGAGTCCAGCTAGGGGCGCTGGTGACCACGCACTTCCTGTACTTGGCCATGTGGGCCTG CGGGGCTCTGGCAGTGTCCCAGCGCTGGCTGCCCCGGGTGGTGTGCAGCTGCTTGTACGGGGTGGCAGCCTCCGCCCTGGGCCTCTTCGT CTTCACTCACCACTGTGCCAGGCGGAGGGACGTGAGAGCCTCGTGGCGCGCCTGCTGCCCCCCTGCCTCTCCCGCGGCCCCCCATGCCCC GCCCCGGGCCCTGCCCGCCGCCGCAGAGGACGGTTCCCCGGTGTTCGGGGAGGGCCCCCCCTCCCTCAAGTCCTCCCCAAGCGGCAGCAG CGGCCATCCGCTGGCTCTGGGCCCCTGCAAGCTCACCAACCTGCAGCTGGCCCAGAGTCAGGTGTGCGAGGCGGGGGCGGCGGCCGGCGG GGAAGGAGAGCCGGAGCCGGCGGGCACCCGGGGAAACCTCGCCCACCGCCACCCCAACAACGTGCACCACGGGCGTCGGGCGCACAAGAG CCGGGCCAAGGGACACCGCGCGGGGGAGGCCTGCGGCAAGAACCGGCTCAAGGCCCTGCGCGGGGGCGCGGCGGGGGCGCTGGAGCTGCT GTCCAGCGAGAGCGGCAGTCTGCACAACAGCCCCACCGACAGCTACCTGGGCAGCAGCCGCAACAGCCCGGGCGCCGGCCTGCAGCTGGA AGGCGAGCCCATGCTCACGCCGTCCGAGGGCAGCGACACCAGCGCCGCGCCGCTTTCTGAGGCGGGCCGGGCAGGCCAGCGCCGCAGCGC CAGCCGCGACAGTCTCAAGGGCGGCGGCGCGCTGGAGAAGGAGAGCCATCGCCGCTCGTACCCGCTCAACGCCGCCAGCCTAAACGGCGC CCCCAAGGGGGGCAAGTACGACGACGTCACCCTGATGGGCGCGGAGGTAGCCAGCGGCGGCTGCATGAAGACCGGACTCTGGAAGAGCGA AACTACCGTCTAAGGTGGGGCGGGCGACGCGGTAGACGGGCTGGCCACGCGGCTCGTTCCCCCGCTCCTCGGGGCCCTCCAAGGTGTCTC CGTAGTCAGCAGGTTGGAGGCAGAGGAGCCGATGGCTGGAGGAAGCCCACAGGCGGATGTTCCCCACTTGCCTAGAGGGCATCCCTCTGG GGTAGCGACAGACAATCCCAGAAACACGCATAATACATTTCCGTCCAGCCCGGGGCAGTCTGACTGTCGGTGCCCTCCCAGGAACGGGGA AGGCCTCCGTCTGTGTGAAAGGGCACAGCACATCCCAGGTGCACCCTCCCCAAGTACTCCCACCCCGCCTACTGTCCATGCGGCCTCACT GGGGGCCATCAGCCTCACCAGCAAAGCAGAGATGAGAGCGTGGGAACTGTGTTCTTTCCTCCCTGCCCTCTACTGATTTCAGCCCAGCCC CTGCCTAGATCCTAGGTCCCTTTTCCTCCCGAGTTTGGCTGGCACGAGAGCTAGCCCAGCACATGAAGCAGGTGATGTTAAGTCACAAGG TGCTGCTTTTCAGATCCACTATGCAAGAGGGGAGGGTGGGGCCACGTGAAAGGCAGCTCTAGACATCAACCAGTCCTGGGGGAGGGGAGT GGGAACCGGGCACAACTAGGAACAATGCCACCATTCCCACAGGAGTGGTACTTAAACCAGACAGCAGGGTTCAGAGGTGGCACACCGGGA CAAAGCTGAGGCCCTGCACCTCAACAGCTGACTGCCAGGTGCCTGTGGGTGAACTGAGGGGAGTAGAGGGAGAGGGCAGGTGGAACTGGG GCAGAATCTAGTCATGCCCTAAAGCTAGTCCTGTAAACAATGGTGCCCCAGAAAGCTGCAGGTGGTGTTTGGAGAAGCAGTTACTTTTCA GTTACAAGACCCATCTCCCTAGTCTCAGCCTTACAACACCACGGGACTAAGGAAGAGCACTTCCTTGCCTCCGTAAGGCCAGAGGAAGAA CCATCCCAATCATTTGATCTCCAGCTCCACAGTAGAGAGAAACCTACAAAATGTCAAACCAGCTTCCCGACTCCCAGGAGCTCAAGCCAA GCCCAGAGGCAGTGGCTGGGGTCCCTGCAGGTCATGAGGGGCCTATGCCTTTACTCCTTTTAAACACCAGCACCCGTCTTTTCCCCAACC TAAAACCAACCACCAGCATTTCACTACAGGACCAAATGGAAACCGAGGGAACCCTGGGTCTTGGGAAGAACAACAGGAAACCAAGGTCTG ACCTAGGGTTCCCTCCCAGTCTTCACATCACTCTGGCCTCATCACCAAGGTGACAGAGGACACAGGGGAGGGGGAAAACCCACACACACT CCTTGGAATGGGTCCTGTTATTTATGCTTGCTGCACAGACATATTAGAAGAAAAAAAAAAGCTTTGTATTATTCTTCCACATATGCTGGC TGCTGTTTACACACCCTGCCAATGCCTTAGCACTGGAGAGCTTTTTGCAATATGCTGGGGAAAGGGGAGGGAGGGAATGAAAGTGCCAAA GAAAACATGTTTTTAAGAACTCGGGTTTTATACAATAGAATGTTTTCTAGCAGATGCCTCTTGTTTTAATATATTAAAATTTTGCAAAGC CCTTTGAGCTACTGCCTTAGTCTACCCACTGTCCTTTTGTTATGAGGTAGAGGATCTCATGACACCATACACACAAACCCATCATTGCCT GTGAATGCACGTAGGGCCAGAATTCCCCAGTTCCCGCTCCTCTGAGGGTTGATACTGCTGGGAATGCCAACCACTCCACAAGCAGAGGGA AGCCCCCTCAGGCCTGCAGGAGGAGCCGCAGCAGTGTGTCCAATTCAAACCAGCAGCAAAGAGCCTGACATTTTCCCATCCATCTATGAG GAAAGCCATCTCACAGAACATGGACATAGGCAACTTGCTCTCCCACACCAAGGGATGGGAATCTCTCCTACCTATAGTCATCCCTGCACT CCTGACTTTACTCCAGGACCCAGGGTCCAACTAATGGCAGAGCCCCTCTTGGTTCCTTCAAACAAGAAAAGCAATACCTACGGACTGGTG TACACTTCCATCCTTGGTTATAACAGGAATGTTATCAAGCTGTCAGAACAGGATGAAGTGCTCCCAGTGGATATCCATCAGGGAGGGTTA GGGACACTCGTGGCAGCCTGTCTAGCAGCCTGGGCTCTCTGAAAGTCCCTAACTTCCTGAGGGGTACGCAAATACTGTTCTATTTCACTA TCAGAAATGTTCTCATCTCCAGTGACAGTGGAGACAGGGGGTACAGGGCAGATCCGCTTCGGGGACTTCAACATGCAGGGTGGCAAGAGA AGGGCAGGACTGGCCGGCCGCTTCCCCTGGGGTAAACCTAAGGAATTATTTCCCACCTCCCCTTCTCCTTGCCCCTGTCCCCACCCCGGT GGCTCCTTCTCTCGGGTCTCCACTTCTGCTGTCCCATCCCGAAAGGCAGAGCGGACCAGTGACTGGCGGTGCTGGAGAAGGTCACCGATG >30243_30243_3_FGFR1-GPR124_FGFR1_chr8_38314874_ENST00000425967_GPR124_chr8_37672414_ENST00000315215_length(amino acids)=1031AA_BP=1 MSNNKITGLRNGSFLGLSLLEKLDLRNNIISTVQPGAFLGLGELKRLDLSNNRIGCLTSETFQGLPRLLRLNISGNIFSSLQPGVFDELP ALKVVDLGTEFLTCDCHLRWLLPWAQNRSLQLSEHTLCAYPSALHAQALGSLQEAQLCCEGALELHTHHLIPSLRQVVFQGDRLPFQCSA SYLGNDTRIRWYHNRAPVEGDEQAGILLAESLIHDCTFITSELTLSHIGVWASGEWECTVSMAQGNASKKVEIVVLETSASYCPAERVAN NRGDFRWPRTLAGITAYQSCLQYPFTSVPLGGGAPGTRASRRCDRAGRWEPGDYSHCLYTNDITRVLYTFVLMPINASNALTLAHQLRVY TAEAASFSDMMDVVYVAQMIQKFLGYVDQIKELVEVMVDMASNLMLVDEHLLWLAQREDKACSRIVGALERIGGAALSPHAQHISVELSA FPREVGGAGAGLHPVVYPCTALLLLCLFATIITYILNHSSIRVSRKGWHMLLNLCFHIAMTSAVFAGGITLTNYQMVCQAVGITLHYSSL STLLWMGVKARVLHKELTWRAPPPQEGDPALPTPSPMLRFYLIAGGIPLIICGITAAVNIHNYRDHSPYCWLVWRPSLGAFYIPVALILL ITWIYFLCAGLRLRGPLAQNPKAGNSRASLEAGEELRGSTRLRGSGPLLSDSGSLLATGSARVGTPGPPEDGDSLYSPGVQLGALVTTHF LYLAMWACGALAVSQRWLPRVVCSCLYGVAASALGLFVFTHHCARRRDVRASWRACCPPASPAAPHAPPRALPAAAEDGSPVFGEGPPSL KSSPSGSSGHPLALGPCKLTNLQLAQSQVCEAGAAAGGEGEPEPAGTRGNLAHRHPNNVHHGRRAHKSRAKGHRAGEACGKNRLKALRGG AAGALELLSSESGSLHNSPTDSYLGSSRNSPGAGLQLEGEPMLTPSEGSDTSAAPLSEAGRAGQRRSASRDSLKGGGALEKESHRRSYPL -------------------------------------------------------------- >30243_30243_4_FGFR1-GPR124_FGFR1_chr8_38314874_ENST00000425967_GPR124_chr8_37672414_ENST00000412232_length(transcript)=5885nt_BP=513nt CCCTTTCACCTCCTGGCTCCCTCCCGGGCGATCCGCGCCCCTTGGGTCTCCCCTCCCTTCCCTCCGTCCGCGTCTCCTGCGCCCCCTCCC TGCGCTCGTCCCGCCGCTCTTCCCGCCGCCCAACTTTTCCTCCAACTCGCGCTCGGGAGCTGGCGAGGCGGCGGCGGCTCCTCAAAGTGG GAGAGCTTCAAGGTCACGTGGTCCGTCCAGCCCCTGCTATCTCACCAGACACTGTCCACCCTGTATGTTGGATCAGTACTCCAGTGAGAA GACAGCAGGCACTTTCACCCATGCAGCCCATTCAGTCTTCATAACCACCTGTGATGGAGGCAAGGGTCAGTTTGAAAAGGAGGATCGAGC TCACTGTGGAGTATCCATGGAGATGTGGAGCCTTGTCACCAACCTCTAACTGCAGAACTGGGATGTGGAGCTGGAAGTGCCTCCTCTTCT GGGCTGTGCTGGTCACAGCCACACTCTGCACCGCTAGGCCGTCCCCGACCTTGCCTGAACAAGGCTCTTGAGCAATAACAAGATCACGGG GCTCCGCAATGGCTCCTTCCTGGGACTGTCACTGCTGGAGAAGCTGGACCTGAGGAACAACATCATCAGCACAGTGCAGCCGGGCGCCTT CCTGGGCCTGGGGGAGCTGAAGCGTTTAGATCTCTCCAACAACCGGATTGGCTGTCTCACCTCCGAGACCTTCCAGGGCCTCCCCAGGCT TCTCCGACTAAACATATCTGGAAACATCTTCTCCAGTCTGCAACCTGGGGTCTTTGATGAGCTGCCAGCCCTTAAGGTTGTGGACTTGGG CACCGAGTTCCTGACCTGTGACTGCCACCTGCGCTGGCTGCTGCCCTGGGCCCAGAATCGCTCCCTGCAGCTGTCGGAACACACGCTCTG TGCTTACCCCAGTGCCCTGCATGCTCAGGCCCTGGGCAGCCTCCAGGAGGCCCAGCTCTGCTGCGAGGGGGCCCTGGAGCTGCACACACA CCACCTCATCCCGTCCCTACGCCAAGTGGTGTTCCAGGGGGATCGGCTGCCCTTCCAGTGCTCTGCCAGCTACCTGGGCAACGACACCCG CATCCGCTGGTACCACAACCGAGCCCCTGTGGAGGGTGATGAGCAGGCGGGCATCCTCCTGGCCGAGAGCCTCATCCACGACTGCACCTT CATCACCAGTGAGCTGACGCTGTCTCACATCGGCGTGTGGGCCTCAGGCGAGTGGGAGTGCACCGTGTCCATGGCCCAAGGCAACGCCAG CAAGAAGGTGGAGATCGTGGTGCTGGAGACCTCTGCCTCCTACTGCCCCGCCGAGCGTGTTGCCAACAACCGCGGGGACTTCAGGTGGCC CCGAACTCTGGCTGGCATCACAGCCTACCAGTCCTGCCTGCAGTATCCCTTCACCTCAGTGCCCCTGGGCGGGGGTGCCCCGGGCACCCG AGCCTCCCGCCGGTGTGACCGTGCCGGCCGCTGGGAGCCAGGGGACTACTCCCACTGTCTCTACACCAACGACATCACCAGGGTGCTGTA CACCTTCGTGCTGATGCCCATCAATGCCTCCAATGCGCTGACCCTGGCTCACCAGCTGCGCGTGTACACAGCCGAGGCCGCTAGCTTTTC AGACATGATGGATGTAGTCTATGTGGCTCAGATGATCCAGAAATTTTTGGGTTATGTCGACCAGATCAAAGAGCTGGTAGAGGTGATGGT GGACATGGCCAGCAACCTGATGCTGGTGGACGAGCACCTGCTGTGGCTGGCCCAGCGCGAGGACAAGGCCTGCAGCCGCATCGTGGGTGC CCTGGAGCGCATTGGGGGGGCCGCCCTCAGCCCCCATGCCCAGCACATCTCAGTGAATGCGAGGAACGTGGCATTGGAGGCCTACCTCAT CAAGCCGCACAGCTACGTGGGCCTGACCTGCACAGCCTTCCAGAGGAGGGAGGGAGGGGTGCCGGGCACACGGCCAGGAAGCCCTGGCCA GAACCCCCCACCTGAGCCCGAGCCCCCAGCTGACCAGCAGCTCCGCTTCCGCTGCACCACCGGGAGGCCCAATGTTTCTCTGTCGTCCTT CCACATCAAGAACAGCGTGGCCCTGGCCTCCATCCAGCTGCCCCCGAGTCTATTCTCATCCCTTCCGGCTGCCCTGGCTCCCCCGGTGCC CCCAGACTGCACCCTGCAACTGCTCGTCTTCCGAAATGGCCGCCTCTTCCACAGCCACAGCAACACCTCCCGCCCTGGAGCTGCTGGGCC TGGCAAGAGGCGTGGCGTGGCCACCCCCGTCATCTTCGCAGGAACCAGTGGCTGTGGCGTGGGAAACCTGACAGAGCCAGTGGCCGTTTC GCTGCGGCACTGGGCTGAGGGAGCCGAACCTGTGGCCGCTTGGTGGAGCCAGGAGGGGCCCGGGGAGGCTGGGGGCTGGACCTCGGAGGG CTGCCAGCTCCGCTCCAGCCAGCCCAATGTCAGCGCCCTGCACTGCCAGCACTTGGGCAATGTGGCCGTGCTCATGGAGCTGAGCGCCTT TCCCAGGGAGGTGGGGGGCGCCGGGGCAGGGCTGCACCCCGTGGTATACCCCTGCACGGCCTTGCTGCTGCTCTGCCTCTTCGCCACCAT CATCACCTACATCCTCAACCACAGCTCCATCCGTGTGTCCCGGAAAGGCTGGCACATGCTGCTGAACTTGTGCTTCCACATAGCCATGAC CTCTGCTGTCTTTGCGGGGGGCATCACACTCACCAACTACCAGATGGTCTGCCAGGCGGTGGGCATCACCCTGCACTACTCCTCCCTATC CACGCTGCTCTGGATGGGCGTGAAGGCGCGAGTGCTCCATAAGGAGCTCACCTGGAGGGCACCCCCTCCGCAAGAAGGGGACCCCGCTCT GCCTACTCCCAGTCCTATGCTCCGGTTCTATTTGATCGCTGGAGGGATTCCACTCATTATCTGTGGCATCACAGCTGCAGTCAACATCCA CAACTACCGGGACCACAGCCCCTACTGCTGGCTGGTGTGGCGTCCAAGCCTTGGCGCCTTCTACATCCCTGTGGCTTTGATTCTGCTCAT CACCTGGATCTATTTCCTGTGCGCCGGGCTACGCTTACGGGGTCCTCTGGCACAGAACCCCAAGGCGGGCAACAGCAGGGCCTCCCTGGA GGCAGGGGAGGAGCTGAGGGGTTCCACCAGGCTCAGGGGCAGCGGCCCCCTCCTGAGTGACTCAGGTTCCCTTCTTGCTACTGGGAGCGC GCGAGTGGGGACGCCCGGGCCCCCGGAGGATGGTGACAGCCTCTATTCTCCGGGAGTCCAGCTAGGGGCGCTGGTGACCACGCACTTCCT GTACTTGGCCATGTGGGCCTGCGGGGCTCTGGCAGTGTCCCAGCGCTGGCTGCCCCGGGTGGTGTGCAGCTGCTTGTACGGGGTGGCAGC CTCCGCCCTGGGCCTCTTCGTCTTCACTCACCACTGTGCCAGGCGGAGGGACGTGAGAGCCTCGTGGCGCGCCTGCTGCCCCCCTGCCTC TCCCGCGGCCCCCCATGCCCCGCCCCGGGCCCTGCCCGCCGCCGCAGAGGACGGTTCCCCGGTGTTCGGGGAGGGCCCCCCCTCCCTCAA GTCCTCCCCAAGCGGCAGCAGCGGCCATCCGCTGGCTCTGGGCCCCTGCAAGCTCACCAACCTGCAGCTGGCCCAGAGTCAGGTGTGCGA GGCGGGGGCGGCGGCCGGCGGGGAAGGAGAGCCGGAGCCGGCGGGCACCCGGGGAAACCTCGCCCACCGCCACCCCAACAACGTGCACCA CGGGCGTCGGGCGCACAAGAGCCGGGCCAAGGGACACCGCGCGGGGGAGGCCTGCGGCAAGAACCGGCTCAAGGCCCTGCGCGGGGGCGC GGCGGGGGCGCTGGAGCTGCTGTCCAGCGAGAGCGGCAGTCTGCACAACAGCCCCACCGACAGCTACCTGGGCAGCAGCCGCAACAGCCC GGGCGCCGGCCTGCAGCTGGAAGGCGAGCCCATGCTCACGCCGTCCGAGGGCAGCGACACCAGCGCCGCGCCGCTTTCTGAGGCGGGCCG GGCAGGCCAGCGCCGCAGCGCCAGCCGCGACAGTCTCAAGGGCGGCGGCGCGCTGGAGAAGGAGAGCCATCGCCGCTCGTACCCGCTCAA CGCCGCCAGCCTAAACGGCGCCCCCAAGGGGGGCAAGTACGACGACGTCACCCTGATGGGCGCGGAGGTAGCCAGCGGCGGCTGCATGAA GACCGGACTCTGGAAGAGCGAAACTACCGTCTAAGGTGGGGCGGGCGACGCGGTAGACGGGCTGGCCACGCGGCTCGTTCCCCCGCTCCT CGGGGCCCTCCAAGGTGTCTCCGTAGTCAGCAGGTTGGAGGCAGAGGAGCCGATGGCTGGAGGAAGCCCACAGGCGGATGTTCCCCACTT GCCTAGAGGGCATCCCTCTGGGGTAGCGACAGACAATCCCAGAAACACGCATAATACATTTCCGTCCAGCCCGGGGCAGTCTGACTGTCG GTGCCCTCCCAGGAACGGGGAAGGCCTCCGTCTGTGTGAAAGGGCACAGCACATCCCAGGTGCACCCTCCCCAAGTACTCCCACCCCGCC TACTGTCCATGCGGCCTCACTGGGGGCCATCAGCCTCACCAGCAAAGCAGAGATGAGAGCGTGGGAACTGTGTTCTTTCCTCCCTGCCCT CTACTGATTTCAGCCCAGCCCCTGCCTAGATCCTAGGTCCCTTTTCCTCCCGAGTTTGGCTGGCACGAGAGCTAGCCCAGCACATGAAGC AGGTGATGTTAAGTCACAAGGTGCTGCTTTTCAGATCCACTATGCAAGAGGGGAGGGTGGGGCCACGTGAAAGGCAGCTCTAGACATCAA CCAGTCCTGGGGGAGGGGAGTGGGAACCGGGCACAACTAGGAACAATGCCACCATTCCCACAGGAGTGGTACTTAAACCAGACAGCAGGG TTCAGAGGTGGCACACCGGGACAAAGCTGAGGCCCTGCACCTCAACAGCTGACTGCCAGGTGCCTGTGGGTGAACTGAGGGGAGTAGAGG GAGAGGGCAGGTGGAACTGGGGCAGAATCTAGTCATGCCCTAAAGCTAGTCCTGTAAACAATGGTGCCCCAGAAAGCTGCAGGTGGTGTT TGGAGAAGCAGTTACTTTTCAGTTACAAGACCCATCTCCCTAGTCTCAGCCTTACAACACCACGGGACTAAGGAAGAGCACTTCCTTGCC TCCGTAAGGCCAGAGGAAGAACCATCCCAATCATTTGATCTCCAGCTCCACAGTAGAGAGAAACCTACAAAATGTCAAACCAGCTTCCCG ACTCCCAGGAGCTCAAGCCAAGCCCAGAGGCAGTGGCTGGGGTCCCTGCAGGTCATGAGGGGCCTATGCCTTTACTCCTTTTAAACACCA GCACCCGTCTTTTCCCCAACCTAAAACCAACCACCAGCATTTCACTACAGGACCAAATGGAAACCGAGGGAACCCTGGGTCTTGGGAAGA ACAACAGGAAACCAAGGTCTGACCTAGGGTTCCCTCCCAGTCTTCACATCACTCTGGCCTCATCACCAAGGTGACAGAGGACACAGGGGA GGGGGAAAACCCACACACACTCCTTGGAATGGGTCCTGTTATTTATGCTTGCTGCACAGACATATTAGAAGAAAAAAAAAAGCTTTGTAT TATTCTTCCACATATGCTGGCTGCTGTTTACACACCCTGCCAATGCCTTAGCACTGGAGAGCTTTTTGCAATATGCTGGGGAAAGGGGAG GGAGGGAATGAAAGTGCCAAAGAAAACATGTTTTTAAGAACTCGGGTTTTATACAATAGAATGTTTTCTAGCAGATGCCTCTTGTTTTAA >30243_30243_4_FGFR1-GPR124_FGFR1_chr8_38314874_ENST00000425967_GPR124_chr8_37672414_ENST00000412232_length(amino acids)=1248AA_BP=1 MSNNKITGLRNGSFLGLSLLEKLDLRNNIISTVQPGAFLGLGELKRLDLSNNRIGCLTSETFQGLPRLLRLNISGNIFSSLQPGVFDELP ALKVVDLGTEFLTCDCHLRWLLPWAQNRSLQLSEHTLCAYPSALHAQALGSLQEAQLCCEGALELHTHHLIPSLRQVVFQGDRLPFQCSA SYLGNDTRIRWYHNRAPVEGDEQAGILLAESLIHDCTFITSELTLSHIGVWASGEWECTVSMAQGNASKKVEIVVLETSASYCPAERVAN NRGDFRWPRTLAGITAYQSCLQYPFTSVPLGGGAPGTRASRRCDRAGRWEPGDYSHCLYTNDITRVLYTFVLMPINASNALTLAHQLRVY TAEAASFSDMMDVVYVAQMIQKFLGYVDQIKELVEVMVDMASNLMLVDEHLLWLAQREDKACSRIVGALERIGGAALSPHAQHISVNARN VALEAYLIKPHSYVGLTCTAFQRREGGVPGTRPGSPGQNPPPEPEPPADQQLRFRCTTGRPNVSLSSFHIKNSVALASIQLPPSLFSSLP AALAPPVPPDCTLQLLVFRNGRLFHSHSNTSRPGAAGPGKRRGVATPVIFAGTSGCGVGNLTEPVAVSLRHWAEGAEPVAAWWSQEGPGE AGGWTSEGCQLRSSQPNVSALHCQHLGNVAVLMELSAFPREVGGAGAGLHPVVYPCTALLLLCLFATIITYILNHSSIRVSRKGWHMLLN LCFHIAMTSAVFAGGITLTNYQMVCQAVGITLHYSSLSTLLWMGVKARVLHKELTWRAPPPQEGDPALPTPSPMLRFYLIAGGIPLIICG ITAAVNIHNYRDHSPYCWLVWRPSLGAFYIPVALILLITWIYFLCAGLRLRGPLAQNPKAGNSRASLEAGEELRGSTRLRGSGPLLSDSG SLLATGSARVGTPGPPEDGDSLYSPGVQLGALVTTHFLYLAMWACGALAVSQRWLPRVVCSCLYGVAASALGLFVFTHHCARRRDVRASW RACCPPASPAAPHAPPRALPAAAEDGSPVFGEGPPSLKSSPSGSSGHPLALGPCKLTNLQLAQSQVCEAGAAAGGEGEPEPAGTRGNLAH RHPNNVHHGRRAHKSRAKGHRAGEACGKNRLKALRGGAAGALELLSSESGSLHNSPTDSYLGSSRNSPGAGLQLEGEPMLTPSEGSDTSA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for FGFR1-GPR124 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FGFR1-GPR124 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | FGFR1 | P11362 | DB00039 | Palifermin | Agonist | Biotech | Approved |
Hgene | FGFR1 | P11362 | DB00039 | Palifermin | Agonist | Biotech | Approved |
Hgene | FGFR1 | P11362 | DB00039 | Palifermin | Agonist | Biotech | Approved |
Hgene | FGFR1 | P11362 | DB00039 | Palifermin | Agonist | Biotech | Approved |
Hgene | FGFR1 | P11362 | DB00039 | Palifermin | Agonist | Biotech | Approved |
Hgene | FGFR1 | P11362 | DB00039 | Palifermin | Agonist | Biotech | Approved |
Hgene | FGFR1 | P11362 | DB00039 | Palifermin | Agonist | Biotech | Approved |
Hgene | FGFR1 | P11362 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB09079 | Nintedanib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB09079 | Nintedanib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB09079 | Nintedanib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB09079 | Nintedanib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB09079 | Nintedanib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB09079 | Nintedanib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB09079 | Nintedanib | Inhibitor | Small molecule | Approved |
Hgene | FGFR1 | P11362 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB01109 | Heparin | Small molecule | Approved|Investigational | |
Hgene | FGFR1 | P11362 | DB01109 | Heparin | Small molecule | Approved|Investigational | |
Hgene | FGFR1 | P11362 | DB01109 | Heparin | Small molecule | Approved|Investigational | |
Hgene | FGFR1 | P11362 | DB01109 | Heparin | Small molecule | Approved|Investigational | |
Hgene | FGFR1 | P11362 | DB01109 | Heparin | Small molecule | Approved|Investigational | |
Hgene | FGFR1 | P11362 | DB01109 | Heparin | Small molecule | Approved|Investigational | |
Hgene | FGFR1 | P11362 | DB01109 | Heparin | Small molecule | Approved|Investigational | |
Hgene | FGFR1 | P11362 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB08901 | Ponatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB09078 | Lenvatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB09078 | Lenvatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB09078 | Lenvatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB09078 | Lenvatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB09078 | Lenvatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB09078 | Lenvatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB09078 | Lenvatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12147 | Erdafitinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12147 | Erdafitinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12147 | Erdafitinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12147 | Erdafitinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12147 | Erdafitinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12147 | Erdafitinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB12147 | Erdafitinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15102 | Pemigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15102 | Pemigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15102 | Pemigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15102 | Pemigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15102 | Pemigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15102 | Pemigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15102 | Pemigatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15685 | Selpercatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15685 | Selpercatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15685 | Selpercatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15685 | Selpercatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15685 | Selpercatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15685 | Selpercatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15685 | Selpercatinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
Hgene | FGFR1 | P11362 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for FGFR1-GPR124 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FGFR1 | C1563720 | Kallmann Syndrome 2 (disorder) | 18 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR1 | C1845146 | Holoprosencephaly, Ectrodactyly, and Bilateral Cleft Lip-Palate | 6 | GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR1 | C0011570 | Mental Depression | 5 | PSYGENET |
Hgene | FGFR1 | C0011581 | Depressive disorder | 5 | CTD_human;PSYGENET |
Hgene | FGFR1 | C0220658 | Pfeiffer Syndrome | 5 | GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR1 | C0432283 | Osteoglophonic dwarfism | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR1 | C0041696 | Unipolar Depression | 4 | CTD_human;PSYGENET |
Hgene | FGFR1 | C0406612 | Encephalocraniocutaneous lipomatosis | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR1 | C0005586 | Bipolar Disorder | 3 | PSYGENET |
Hgene | FGFR1 | C0795998 | JACKSON-WEISS SYNDROME | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR1 | C1269683 | Major Depressive Disorder | 3 | PSYGENET |
Hgene | FGFR1 | C0006142 | Malignant neoplasm of breast | 2 | CGI;CTD_human |
Hgene | FGFR1 | C0007131 | Non-Small Cell Lung Carcinoma | 2 | CTD_human |
Hgene | FGFR1 | C0007137 | Squamous cell carcinoma | 2 | CTD_human |
Hgene | FGFR1 | C0027022 | Myeloproliferative disease | 2 | CTD_human |
Hgene | FGFR1 | C0162809 | Kallmann Syndrome | 2 | CTD_human;ORPHANET |
Hgene | FGFR1 | C0432122 | Interfrontal craniofaciosynostosis | 2 | GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR1 | C0678222 | Breast Carcinoma | 2 | CGI;CTD_human |
Hgene | FGFR1 | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human |
Hgene | FGFR1 | C1458155 | Mammary Neoplasms | 2 | CTD_human |
Hgene | FGFR1 | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human |
Hgene | FGFR1 | C0004114 | Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0008924 | Cleft upper lip | 1 | CTD_human |
Hgene | FGFR1 | C0008925 | Cleft Palate | 1 | CTD_human |
Hgene | FGFR1 | C0010278 | Craniosynostosis | 1 | CTD_human;GENOMICS_ENGLAND |
Hgene | FGFR1 | C0011573 | Endogenous depression | 1 | CTD_human |
Hgene | FGFR1 | C0017638 | Glioma | 1 | CTD_human |
Hgene | FGFR1 | C0018824 | Heart valve disease | 1 | CTD_human |
Hgene | FGFR1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Hgene | FGFR1 | C0025193 | Melancholia | 1 | CTD_human |
Hgene | FGFR1 | C0036341 | Schizophrenia | 1 | CTD_human |
Hgene | FGFR1 | C0085682 | Hypophosphatemia | 1 | GENOMICS_ENGLAND |
Hgene | FGFR1 | C0086133 | Depressive Syndrome | 1 | CTD_human |
Hgene | FGFR1 | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
Hgene | FGFR1 | C0205768 | Subependymal Giant Cell Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0206726 | gliosarcoma | 1 | ORPHANET |
Hgene | FGFR1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Hgene | FGFR1 | C0259783 | mixed gliomas | 1 | CTD_human |
Hgene | FGFR1 | C0265535 | Trigonocephaly | 1 | CTD_human;ORPHANET |
Hgene | FGFR1 | C0280783 | Juvenile Pilocytic Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0280785 | Diffuse Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0282126 | Depression, Neurotic | 1 | CTD_human |
Hgene | FGFR1 | C0334579 | Anaplastic astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0334580 | Protoplasmic astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0334581 | Gemistocytic astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0334582 | Fibrillary Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0334583 | Pilocytic Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0334588 | Giant Cell Glioblastoma | 1 | ORPHANET |
Hgene | FGFR1 | C0338070 | Childhood Cerebral Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0338503 | Septo-Optic Dysplasia | 1 | ORPHANET |
Hgene | FGFR1 | C0342384 | Idiopathic hypogonadotropic hypogonadism | 1 | GENOMICS_ENGLAND |
Hgene | FGFR1 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |
Hgene | FGFR1 | C0431362 | Lobar Holoprosencephaly | 1 | ORPHANET |
Hgene | FGFR1 | C0547065 | Mixed oligoastrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0555198 | Malignant Glioma | 1 | CTD_human |
Hgene | FGFR1 | C0750935 | Cerebral Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0750936 | Intracranial Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C0751617 | Semilobar Holoprosencephaly | 1 | ORPHANET |
Hgene | FGFR1 | C1519086 | Pilomyxoid astrocytoma | 1 | ORPHANET |
Hgene | FGFR1 | C1704230 | Grade I Astrocytoma | 1 | CTD_human |
Hgene | FGFR1 | C1837218 | Cleft palate, isolated | 1 | CTD_human |
Hgene | FGFR1 | C1852406 | Cutis Gyrata Syndrome of Beare And Stevenson | 1 | GENOMICS_ENGLAND |
Hgene | FGFR1 | C2931196 | Craniofacial dysostosis type 1 | 1 | GENOMICS_ENGLAND |
Hgene | FGFR1 | C3150773 | CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME | 1 | ORPHANET |